Explore the positions available across Oxford Science Enterprises

Scenic Biotech

scenicbiotech.com

Scenic Biotech is advancing Modifier Therapy, a radically new approach to treating genetic disorders. Instead of targeting the primary disease-causing mutation, Modifier Therapy seeks to rebalance health by acting on another function in the genome that can neutralize the disease impact, leading to a therapeutic effect. Our robust pipeline, derived from our proprietary Cell-seq™ platform, includes first-in-class small molecule programs that are either wholly owned or partnered through strategic collaborations with multinational pharmaceutical leaders. By unlocking new pathways in the genome, Scenic will develop a range of Modifier Therapies to help patients.